Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05296499
Other study ID # 254956
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 20, 2019
Est. completion date April 20, 2023

Study information

Verified date March 2022
Source Guy's and St Thomas' NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Deep vein thrombosis (DVT) can cause long-term scarring and narrowing of veins. When there is extensive damage to the veins in the legs, groin or abdomen it can affect the way that blood is able to flow back up to the heart. Some patients are left with severe symptoms such as pain, leg swelling and ulcers, and have surgical treatment with nitinol stents to re-open the veins and relieve symptoms. The primary aim of this study is to investigate venous blood flow to the heart during exercise in patients with extensive damage to the veins in the groin and abdomen after DVT, and changes that happen after stenting.


Description:

Participants will have cardiopulmonary exercise testing, 6 minute walk test and basic blood tests to establish exercise tolerance and rule out other heart and lung conditions. Exercise cardiac MRI will be used to evaluate cardiac function during exercise. All participants will complete generic and disease specific quality of life questionnaires. Participants who are having a stenting procedure will repeat assessments 6-8 weeks after surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 56
Est. completion date April 20, 2023
Est. primary completion date October 20, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: All groups: ->16 years of age - Consent to participate in the research study and be willing to commit to study requirements, including completion of questionnaires and follow up visits. Group 1: - Venous thrombosis/obstruction involving the inferior vena cava >12 months ago. - Symptoms of exertional dyspnoea reported by patient. - Judged by the chief investigator as suitable for surgical intervention before recruitment to the study. - Agree to adhere to therapeutic anticoagulation after surgical intervention. Group 2: - Venous thrombosis/obstruction involving the inferior vena cava >12 months ago. - Under the clinical care of the deep venous service for surveillance of symptoms. Group 3: - Unilateral Iliofemoral venous thrombosis /obstruction >12 months ago. - Judged by the chief investigator as suitable for surgical intervention before recruitment to the study. - Agree to adhere to therapeutic anticoagulation after surgical intervention. Exclusion Criteria: All groups: - DVT or PE in last 12 months - Significant or untreated left sided heart disease (eg coronary artery disease, LV dysfunction, valvular abnormalities, congenital heart disease, chronic or paroxysmal arrhythmias) - Significant or untreated chronic lung disease (eg asthma, COPD, ILD) - Moderate to severe renal disease - Moderate to severe liver disease - Peripheral arterial disease - Significant neurological or musculoskeletal disease - Cognitive impairment or learning disabilities - Pregnant or planning to become pregnant in next 12 months - Active cancer (primary, metastatic or treated within last 6 months) - Life expectancy < 2 years or chronic non-ambulatory status. - Any other contraindication to exercise. - Any contraindications to MRI scanning - Inability to provide informed consent or comply with study assessments (e.g. due to cognitive impairment, physical limitations or geographic distance). Group 4: All of the above, plus: - Previous DVT or PE - Known, or clinical signs of chronic venous disease as judged by the chief investigator e.g. varicose veins, leg ulcers.

Study Design


Intervention

Diagnostic Test:
Cardiopulmonary exercise test (CPET)
Cardiopulmonary exercise testing using cycle ergonomenter
Exercise cardiac MRI
Exercise cardiac MRI using supine cycle, participants exercised to peak workload as determined by CPET
Other:
6 minute walk test
6MWT
Diagnostic Test:
Blood tests
FBC, U&E, LFTS
Other:
Quality of life questionnaires
SF36, EQ5D, VEINES-QoL/Sym
Repeat baseline assessments
repeat baseline
Diagnostic Test:
MR venogram
MRI scan of venous system

Locations

Country Name City State
United Kingdom Guys and St Thomas' NHS Foundation Trust London

Sponsors (2)

Lead Sponsor Collaborator
Guy's and St Thomas' NHS Foundation Trust King's College London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary VO2 max after stenting As determined by cardiopulmonary exercise testing 6-8 weeks post surgery
Primary Peak cardiac output during exercise as determined by exercise cardiac MRI 6-8 weeks post surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05744843 - Structured Exercise Versus Endovascular Reconstruction in Post Thrombotic Syndrome N/A
Recruiting NCT05622500 - Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease N/A
Recruiting NCT04250025 - Angioplasty-stenting vs Optimal Medical Treatment on Post-thrombotic Syndrome Reduction N/A
Completed NCT00790335 - Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Phase 3
Completed NCT03075761 - Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT) N/A
Terminated NCT04794569 - Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome Phase 4
Recruiting NCT03368313 - Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis N/A
Terminated NCT04103112 - Compression Hosiery to Avoid Post-Thrombotic Syndrome N/A
Completed NCT00858130 - Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS) N/A
Completed NCT00633971 - Treatment Trial for Post-Thrombotic Syndrome N/A
Recruiting NCT06046807 - Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term).
Not yet recruiting NCT01637428 - The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome Phase 2
Recruiting NCT03250247 - Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) N/A
Completed NCT03054727 - Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )
Completed NCT04825548 - Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol
Withdrawn NCT03039517 - Post Thrombotic Syndrome Prevention Study N/A
Recruiting NCT02268630 - Long Term Outcomes of Venous Thromboembolism N/A
Completed NCT03757481 - Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE N/A
Recruiting NCT04319627 - Statins for Venous Event Reduction in Patients With Venous Thromboembolism Phase 3
Withdrawn NCT04411316 - Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis Phase 4